The Efficacy of Capsaicin Sensitivity Testing in Patients With Irritable Larynx Syndrome
NCT02065128 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2017-08-01
Summary
Irritable larynx syndrome (ILS) is a hyperkinetic laryngeal dysfunction that is characterized by a persistent cough, voice changes, or breathing difficulties, which are often triggered by an irritant. Diagnosis of ILS is difficult and typically made via a thorough review of the clinical history and, occasionally, the patient's reaction to an odor-provocation test. Standard treatment for ILS is behavioural therapy with a speech language pathologist (SLP), which provides symptom improvement for most patients. However, currently, there are no objective measures of the upper airway hyper-responsiveness in this condition to assist in diagnosing and monitoring disease severity.
Since the cough is irritant-based, it is anticipated that patients with ILS will have a hypersensitivity to the irritant capsaicin. Capsaicin is the active component of chili peppers and is what makes them hot. The capsaicin cough challenge is a well recognized test that involves inhaling different concentrations of capsaicin solutions to determine a cough reflex sensitivity.
The purpose of this research study is to confirm that ILS patients have a hypersensitivity to capsaicin compared to healthy volunteers. If a hypersensitivity is observed in ILS patients, the second objective of this study will be to see if behavioural therapy improves the cough reflex sensitivity in this patient population.
Conditions
- Cough
- Larynx
Interventions
- OTHER
-
Capsaicin cough challenge test
The capsaicin cough challenge testing will be conducted in the pulmonary function laboratory at SMH by a pulmonary function technologist. The test involves having the participant inhale increasing concentrations of capsaicin solutions and assessing their response. The tidal breathing method and solution preparation presented by Nejla, et al. 12 will be used to conduct this testing. The tidal breathing method is preferred to the alternative dosimeter method as it produces similar results with lower capsaicin concentrations thereby resulting in less throat irritation for the participant. The technique is detailed in the following sections.
Sponsors & Collaborators
-
Unity Health Toronto
lead OTHER
Principal Investigators
-
Jennifer Anderson, MD, FRCS(C) · Chief, Department of Otolaryngology - Head and Neck Surgery
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-08-01
- Primary Completion
- 2017-08-31
- Completion
- 2017-08-31
Countries
- Canada
Study Locations
More Related Trials
-
A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.
NCT00237068 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Lansoprazole in Chronic Post Nasal Drip
NCT00335283 ·Status: COMPLETED ·Phase: PHASE3
-
Longitudinal Study of Children With a Chronic Cough and the Impact of Gastroesophageal Reflux
NCT00771706 ·Status: WITHDRAWN ·Phase: PHASE3
-
Lansoprazole to Treat Children With Asthma
NCT00442013 ·Status: COMPLETED ·Phase: PHASE4
-
Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Reduction
NCT04383262 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Comparison of Voice Therapy and Antireflex Therapy in LPR
NCT02530879 ·Status: WITHDRAWN ·Phase: PHASE4
-
Cough Reflex Sensitivity and Bronchial Hyper-responsiveness
NCT01777867 ·Status: COMPLETED
-
The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump Inhibitors
NCT01404832 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn
NCT00389948 ·Status: COMPLETED ·Phase: PHASE3
-
Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy
NCT01328652 ·Status: UNKNOWN ·Phase: PHASE4
-
Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux
NCT00864396 ·Status: COMPLETED ·Phase: PHASE1
-
Buspirone for Weak or Absent Esophageal Peristalsis
NCT05629325 ·Status: RECRUITING ·Phase: PHASE4
-
Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment?
NCT00444145 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime Heartburn
NCT00701259 ·Status: COMPLETED ·Phase: PHASE3
-
Chronic Posterior Laryngitis With Suspected Laryngopharyngeal Reflux
NCT00628667 ·Status: COMPLETED ·Phase: PHASE4
-
Tolerability Study of a Novel Microbiome Therapeutic in Subjects With Gastroesophageal Reflux Disease
NCT04491734 ·Status: COMPLETED ·Phase: NA
-
Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn
NCT00390390 ·Status: COMPLETED ·Phase: PHASE3
-
Esophageal capsaïcin Infusion and Mucosal Integrity
NCT02603783 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Ilaprazole to Treat Erosive Esophgitis
NCT01509261 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole
NCT00132496 ·Status: COMPLETED ·Phase: PHASE2
-
Dietary Control Alone Versus Dietary Control Plus Use of Proton Pump Inhibitors to Treat Pediatric Hoarseness
NCT00637416 ·Status: TERMINATED ·Phase: PHASE4
-
Trial of Proton Pump Inhibitor With Prokinetics or Placebo in Patients With Laryngopharyngeal Reflux Disease
NCT02533349 ·Status: UNKNOWN ·Phase: PHASE3
-
Bedside Screening Method for Patients With Potential Swallowing Impairment
NCT01158313 ·Status: COMPLETED
-
Validation of Peptest™ for the Detection of Reflux in Cough
NCT03851393 ·Status: COMPLETED ·Phase: NA
-
Acceptability and Tolerance Study of a Thickener
NCT05026476 ·Status: COMPLETED